Cargando…
Drug-Induced Liver Injury From Sacubitril-Valsartan Versus a Single Dose of Acarbose
Numerous known medications can induce liver injury. Sacubitril-valsartan was approved by the Food and Drug Administration in 2015 for use in patients with chronic heart failure to reduce the rate of cardiovascular death and hospitalizations related to heart failure. There are yet to be any reported...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386752/ https://www.ncbi.nlm.nih.gov/pubmed/35989811 http://dx.doi.org/10.7759/cureus.27005 |